Promising radioactive treatment shows up to 75% response in tough childhood cancer
Disease control
AVAILABLE
This expanded access program provides a radioactive drug called 131 I-MIBG to children (age 1 and older) with neuroblastoma that has not responded to standard treatments or has come back. The drug targets and kills cancer cells with radiation. Early results from a related study s…
Sponsor: John Maris • Aim: Disease control
Last updated May 01, 2026 16:00 UTC